These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28735812)

  • 1. Reply to: "β-blocker treatment of vascular disease in cocaine addiction".
    Bachi K; Mani V; Trivieri MG; Jeyachandran D; Fayad ZA; Goldstein RZ; Alia-Klein N
    Atherosclerosis; 2017 Sep; 264():123-124. PubMed ID: 28735812
    [No Abstract]   [Full Text] [Related]  

  • 2. β-blocker treatment of vascular disease in cocaine addiction.
    Richards JR
    Atherosclerosis; 2017 Sep; 264():122. PubMed ID: 28633764
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular disease in cocaine addiction.
    Bachi K; Mani V; Jeyachandran D; Fayad ZA; Goldstein RZ; Alia-Klein N
    Atherosclerosis; 2017 Jul; 262():154-162. PubMed ID: 28363516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial therapeutics: the β-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma.
    Schurr JW; Gitman B; Belchikov Y
    Pharmacotherapy; 2014 Dec; 34(12):1269-81. PubMed ID: 25224512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Blocker in Acute Cocaine Toxicity: Is It Safe?
    Subramanian S; Sampathkumar S; Menezes RG; Thirumalaikolundusubramanian P
    J Emerg Med; 2017 Oct; 53(4):570. PubMed ID: 29079073
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to β-Blocker in Acute Cocaine Toxicity: Is It Safe?
    Richards JR; Laurin EG; Tabish N; Lange RA
    J Emerg Med; 2017 Oct; 53(4):571-572. PubMed ID: 29079074
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating cocaine cardiotoxicity: Does receptor subtype matter?
    Long VP; Carnes CA
    Trends Cardiovasc Med; 2015 Aug; 25(6):527-8. PubMed ID: 25682914
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-Blocker Management of Cocaine-Induced Chest Pain.
    Richards JR
    Cardiol Rev; 2016; 24(6):324. PubMed ID: 27548690
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying patients with cocaine-related chest pain at true risk for beta-blocker toxicity.
    Canning J; Brooks DE; Gerkin RD
    Arch Intern Med; 2010 Nov; 170(20):1859; author reply 1860. PubMed ID: 21059983
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcomes of Β-blocker therapy in cocaine-associated heart failure.
    Lopez PD; Akinlonu A; Mene-Afejuku TO; Dumancas C; Saeed M; Cativo EH; Visco F; Mushiyev S; Pekler G
    Int J Cardiol; 2019 Feb; 277():153-158. PubMed ID: 30146248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study.
    Cediel G; Carrillo X; García-García C; Rueda F; Oliveras T; Labata C; Serra J; Ferrer M; de Diego O; Bayés-Genís A
    Int J Cardiol; 2018 Jun; 260():7-10. PubMed ID: 29622456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta blocker treatment of heart failure patients with ongoing cocaine use.
    Littmann L; Narveson SY; Fesel NM; Marconi SL
    Int J Cardiol; 2013 Oct; 168(3):2919-20. PubMed ID: 23664043
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging pharmacological strategies in the fight against cocaine addiction.
    Sofuoglu M; Kosten TR
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):91-8. PubMed ID: 16503828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain.
    Fanari Z; Kennedy KK; Lim MJ; Laddu AA; Stolker JM
    Am J Cardiol; 2014 Jun; 113(11):1802-6. PubMed ID: 24742472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of β-blocker Therapy on Hospital Readmission and Mortality in Heart Failure Patients With Concurrent Cocaine Use.
    Egbuche O; Ekechukwu I; Effoe V; Maduabum N; Millard HR; Maihemuti A; Cross JA; Adedinsewo D; Onwuanyi AE
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):518-523. PubMed ID: 29793347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular consequences of cocaine use.
    Stankowski RV; Kloner RA; Rezkalla SH
    Trends Cardiovasc Med; 2015 Aug; 25(6):517-26. PubMed ID: 25657055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers and cocaine: still a bad idea.
    Gupta AK; Greller HA; Hoffman RS
    Arch Intern Med; 2010 Nov; 170(20):1859-60; author reply 1860. PubMed ID: 21059982
    [No Abstract]   [Full Text] [Related]  

  • 18. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon.
    Richards JR; Hollander JE; Ramoska EA; Fareed FN; Sand IC; Izquierdo Gómez MM; Lange RA
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):239-249. PubMed ID: 28399647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labetalol and cardiovascular consequences of cocaine use.
    Richards JR; Lange RA
    Trends Cardiovasc Med; 2016 Feb; 26(2):202-3. PubMed ID: 26116092
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
    Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C
    Ann Emerg Med; 2008 Feb; 51(2):117-25. PubMed ID: 17583376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.